The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain

Palliative Medicine

Volumn 24, Issue 1, 2010, Pages 9-16

  Lasheen, Wael ^a   Walsh, Declan ^a   Mahmoud, Fade ^a   Sarhill, Nabeel ^a   Rivera, Nilo ^a   Davis, Mellar ^a   Lagman, Ruth ^a   Legrand, Susan ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Cancer; Equianalgesic; Intravenous; Morphine; Pain

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; MORPHINE; NARCOTIC ANALGESIC AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; COHORT ANALYSIS; CONTINUOUS INFUSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; STATISTICS;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 75149192577     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216309346595     Document Type: Article

References (31)

1. World Health Organization. (1986). Cancer pain relief program. Geneva: WHO, 1986.
2. Glare PA, Walsh TD Clinical pharmacokinetics of morphine. Therapeutic Drug Monitoring 1991 ; 13: 1-23.
3. Glare P. Morphine. In: Davis MP, Glare P, Hardy J (eds) Opioids in cancer pain. New York: Oxford University Press, 2005, p. 91-120.
4. Jackson KC Opioid pharmacokinetics. In: Davis MP, Glare P, Hardy J (eds) Opioids in cancer pain. New York: Oxford University Press, 2005, p. 43-52.
5. Somogyi AA, Nation RL, Olweny C., et al. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine. Clin Pharmacokinet 1993 ; 24: 413-420.
6. Tiseo PJ, Thaler HT, Lapin J., Inturrisi CE, Portenoy RK, Foley KM Morphine-6-glucuronide concentrations and opioid- related side effects: A survey in cancer patients. Pain 1995 ; 61: 47-54.
7. Faura CC, Moore RA, Horga JF, Hand CW, McQuay HJ Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain. J Pain Symptom Manage 1996 ; 11: 95-102.
8. Klepstad P., Kaasa S., Borchgrevink PC Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol 2000 ; 55: 713-719.
9. Davis MP, Pasternak GW Opioid receptors and opioid pharmacodynamics. In: Davis MP, Glare P, Hardy J (eds) Opioids in cancer pain. New York: Oxford University Press, 2005, p. 11-42.
10. Walsh TD Oral morphine in chronic cancer pain. Pain 1984 ; 18: 1-11.
11. Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hospice Palliat Care 2004 ; 21: 137-142.
12. Houde RW, Wallenstein SL, Beaver WT Clinical measurement of pain. In: de Stevens G (ed.) Analgesics. New York: Academic Press, 1965, p. 75-122.
13. Hanks GW, Hoskin PJ, Aherne GW, et al. Explanation for potency of repeated oral doses of morphine. Lancet 1987 ; 26: 723-724.
14. Hanks GW, Rose MM, Aherne GW, Piall EM Analgesic effects of morphine tablets. Lancet 1981 ; 1: 732-733.
15. McQuay HJ, Moore RA, Hand CW, Sear JW Potency of oral morphine. Lancet 1987 ; 2: 1458-1489.
16. Kaiko RF The therapeutic equivalence of IM and PO administration of morphine-1: 3 or 1: 6. J Palliat Care 1988 ; 4: 64-66.
17. Twycross RG The therapeutic equivalence of oral and subcutaneous/ intramuscular morphine sulphate in cancer patients. J Palliat Care 1988 ; 4: 67-68.
18. Hanks GW, Conno F., Cherny N., et al. Expert Working Group of the Research Network of the European Association for Palliative Care, Morphine and alternative opioids in cancer pain: The EAPC recommendations. Br J Cancer 2001 ; 84: 587-593.
19. Nelson KA, Glare PA, Walsh D., Groh ES A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage 1997 ; 13: 262-267.
20. De Schepper HU, Cremonini F., Park MI, Camilleri M. Opioids and the gut: Pharmacology and current clinical experience. Neurogastroenterol Motility 2004 ; 16: 383-394.
21. Donnelly S., Davis MP, Walsh D., Naughton M. World Health Organization. Morphine in cancer pain management: A practical guide. Support Care Cancer 2002 ; 10: 13-35.
22. Kalso E., Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 1990 ; 47: 639-646.
23. Takahashi M., Ohara T., Yamanaka H., Shimada A., Nakaho T. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment. Palliat Med 2003 ; 17: 673-678.
24. Sawe J., Dahlstrom B., Paalzow L., Rane A. Morphine kinetics in cancer patients. Clin Pharmacol Therapeut 1981 ; 30: 629-635.
25. Tegeder I., Lotsch J., Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999 ; 37: 17-40.
26. Radominska-Pandya A., Little JM, Pandya JT, et al. UDP- glucuronosyltransferases in human intestinal mucosa. Biochim Biophys Acta 1998 ; 1394: 199-208.
27. Yokokawa N., Hiraga K., Oguma T., Konishi M. Relationship between plasma concentration of morphine and analgesic effectiveness. Postgrad Med J 1991 ; 67 (Suppl 2). S50 - S54.
28. Lotsch J., Skarke C., Liefhold J., Geisslinger G. Genetic predictors of the clinical response to opioid analgesics: Clinical utility and future perspectives. Clin Pharmacokinet 2004 ; 43: 983-1013.
29. Pereira J., Bruera E. Alberta hospice palliative care resource manual, 2 nd edn. Division of Palliative Care Medicine, University of Alberta, 2001.
30. Back IN Palliative medicine handbook, 3 rd edition. Cardiff: BPM Books. Available at: http://book.pallcare.info/index.php?tid=125&searchstring= Approximate%20equivalent%20doses%20of%20strong%20opioid%20analgesics
31. Mercadante S., Villari P., Ferrera P., Casuccio A., Fulfaro F. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer 2002 ; 95: 203-208.